Mast cells in clinical dermatology

Australasian Journal of Dermatology

Volumn 39, Issue 1, 1998, Pages 14-18

  Miyachi, Yoshiki ^a   Kurosawa, Motohiro ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Allergic inflammation; Cytokines; Fibrosis; Mastocytosis; Phototherapy; Remodelling stem cell factor; Tryptase

Indexed keywords

CARBOXYPEPTIDASE; CATHEPSIN G; CHYMASE; HEPARIN; HISTAMINE; INTERLEUKIN 4; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY; CELL ACTIVATION; CELL CULTURE; CELLULAR DISTRIBUTION; DISEASE CLASSIFICATION; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAST CELL; MASTOCYTOSIS; REVIEW;

EID: 0031954968     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1998.tb01234.x     Document Type: Review

References (39)

1. Holgate ST. The immunopharmacology of mild asthma. J. Allergy Clin. Immunol 1996; 98: S7-16.
2. Galli SJ. New concepts about the mast cell. N. Engl. J. Med. 1993; 328: 257-65.
3. Irani A-MA, Bradford TR, Kepley CL, Schechter NM, Schwartz LB. Detection of MCr and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chj-mase antibodies. J. Histochem. Cytochem. 1989; 37: 1509-15.
4. Kurosawa M. Protein phosphorylation and inositol phospholipid metabolism in activated mast cells. Clin. Exp. Allergy 1990; 20: 7-12.
5. Kurosawa M. Phosphorylation and dephosphorylation of protein in regulating cellular function. J. Pharmacol. Toxicol. Methods 1994; 31: 135-9.
6. Benyon RC, Lowman MA, Church MK. Human skin mast cells: Their dispersion, purification, and secretory characterization. J. Immunol. 1987; 138: 861-7.
7. Church MK, Pao GJ-K, Holgate ST. Characterization of histamine secretion from mechanically dispersed human lung mast cells: Effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J. Immunol. 1982; 129: 2116-21.
8. Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int. Arch. Allergy Immunol. 1992; 97: 216-25.
9. Okayama Y, Benyon RC, Rees PH, Lowman MA, Hillier K, Church MK. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin. Exp. Allergy-1992; 22: 401-9.
10. 2 release from mast cells of human lung, tonsil, and skin. Allergy 1994; 49: 246-53.
11. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content J. Immunol. 1995; 155:297-307.
12. Okayama Y, Petit-Frere C, Kassel O et al. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells. J. Immunol. 1995; 155: 1796-808.
13. Kanbe N, Kurosawa M, Miyachi Y. Cultured human mast cells synthesize transforming growth factor l (abstract). Allergy Clin. Immunol. Int. 1997; (Suppl.) 52.
14. Church MK, Levi-Schaffer F. The human mast cell. J. Allergy Clin. Immunol. 1997; 99:155-60.
15. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J. Am. Acad. Dermatol 1995; 32: 545-61.
16. Kurosawa M, Amano II, Kanbe N et al. Heterogeneity of mast cells in mastocytosis and inhibitory effects of ketotifen and ranitidine on the mediators in an indolent systemic mastocytosis. J. Allergy Clin. Immunol. 1998 (in press).
17. Kurosawa M, Amano H, Kanbe N et al. Response to cyclosporin and a low dose of methylprednisolone in aggressive systemic mastocytosis. J. Allergy. Clin. Immunol 1998 (in press).
18. Longley BJ, Morganroth GS, Tyrrell L et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N. Engl J. Med. 1993; 328: 1302-7.
19. Linenberger ML, Jacobson FW, Bennett LG, Broudy VC, Martin FH, Abkowitz JL. Stem cell factor production by human marrow stromal fibroblasts. Exp. Hematol. 1995; 23: 1104-14.
20. Welker P, Grabbe J, Rosenbach T et al. Release of stem cell factor during differentiation of HaCa keratinocytes. J. Invest. Dermatol 1994; 103: 620 (Abstract).
21. Galli SJ, Tsai M, Wershil BK. Regulation of mast cell proliferation, maturation and function by stem cell factor, ligand of c-kit receptor. Int. Arch. Allergy Immunol. 1992; 99: 234-7.
22. Nagata H, Worobec AS, Oh CK et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematological disorder. Proc. Natl Acad. Sci. USA 1995; 92: 10 560-4.
23. Longley BJ, Tyrrell L, Lu S-Z et al. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nature Genetics 1996; 12: 312-14.
24. Saito H, Ebisawa M, Tachimoto H et al. Selective growth of human mast cells induced by steel factor, IL-6 and prostaglandin E2 from cord blood mononuclear cells. J. Immunol. 1996; 137: 343-50.
25. Igarashi Y, Kurosawa M, Ishikawa O et aL Characteristics of histamine release from cultured human mast cells. Clin. Exp. Allergy 1996; 26: 597-602.
26. Li L, Meng XW, Krills SA. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand. J. Immunol. 1996; 156: 4839-44.
27. Leung DY. Atopic dermatitis: The skin as a window into pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol 1995; 96: 302-18.
28. Schwartz LB. Tryptase: A clinical indicator of mast cell-dependent disease. In: Godard PH, Bousquet J, Michel FB (eds). Advances in Allergology and Clinical Immunology. Carnforth: Parthenon Publishing. 1992; 293-304.
29. Kapp A. The role of eosinophils in the. pathogenesis of atopic dermatitis: Eosinophil granule proteins as markers of disease activity. Allergy 1993; 48: 1-5.
30. Bruijnzeel PLB, Kuijper PHM, Kapp A, Warringa RAJ, Betz S Bruijnzeel-Koomen CAFM. The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: Its relevance for the pathogenesis of atopic dermatitis. Clin. Exp. Allergy 1993; 23: 97-109.
31. Rothe MJ, Kerdel FA. The mast cell in fibrosis. Int. J. Dermatol 1990; 30: 13-16.
32. Levi-Schaffer F, Rubinchik E. Mast cell/fibroblast interactions. Clin. Exp. Allergy 1994; 24: 1016-21.
33. Gruber BL, Kew RR, Jelaska A et al. Human mast cells activate fibroblasts: Tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J. Immunol. 1997; 158: 2310-17.
34. Stellato C, de Paulis A, Ciccarelli A et al. Anti-inflammatory effects of cyclosporin A on human skin mast cells. J. Invest. Dermatol. 1992; 98: 800-4.
35. Danno K, Toda K, Horio T. Ultraviolet-B radiation suppresses mast cell degranulation induced by compound 48/80. J. Invest. Dermatol. 1986; 87: 775-8.
36. Amano H, Kurosawa M, Miyachi Y. Inhibition of substance P-induced histamine release from rat peritoneal mast cells by ultraviolet light B irradiation: Decreased intracellular calcium as a partial mechanism. Clin. Exp. Allergy 1997; 27: 966-71.
37. Amano H, Kurosawa M, Miyachi Y. Possible mechanisms of the concentration-dependent action of substance P to induce histamine release from rat peritoneal mast cells and the effect of extracellular calcium on the mast cell activation. Allergy 1997; 52: 215-19.
38. Amano H, Kurosawa M, Miyachi Y. Inhibition of substance P-induced histamine release from rat peritoneal mast cells by 8-methoxypsoralen plus long-wave ultraviolet light irradiation (PUVA): Decreased intracellular calcium as a partial mechanism. Int. Arch. Allergy Immunol. 1998 (in press).
39. Amano II, Kurosawa M, Miyachi Y. Inhibition of substance P-induced histamine release from rat peritoneal mast cells by low doses of protoporphyrin plus long-wave ultraviolet light irradiation: Decreased intracellular calcium as a possible mechanism. Clin. Exp. Allergy 1998 (in press).